Abstract

SummaryBackgroundSchistosomiasis is endemic in many low-income and middle-income countries. To reduce infection-associated morbidity, WHO has published guidelines for control of schistosomiasis based on targeted mass drug administration (MDA) and, in 2017, on supplemental snail control. We compared the current WHO guideline-based strategies from 2012 to an alternative, adaptive decision making framework for control in heterogeneous environments, to estimate their predicted relative effectiveness and time to achievement of defined public health goals.MethodsIn this model-based comparison study, we adapted an established transmission model for Schistosoma infection that couples local human and snail populations and includes aspects of snail ecology and parasite biology. We calibrated the model using data from high-risk, moderate-risk, and lower-risk rural villages in Kenya, and then simulated control via MDA. We compared 2012 WHO guidelines with a modified adaptive strategy that tested a lower-prevalence threshold for MDA and shorter intervals between implementation, evaluation, and modification. We also explored the addition of snail control to this modified strategy. The primary outcomes were the proportion of simulations that achieved the WHO targets in children aged 5–14 years of less than 5% (2020 morbidity control goal) and less than 1% (2025 elimination as a public health problem goal) heavy infection and the mean duration of treatment required to achieve these goals.FindingsIn high-risk communities (80% baseline prevalence), current WHO strategies for MDA were not predicted to achieve morbidity control (<5% prevalence of heavy infections) in 80% of simulations over a 10-year period, whereas the modified adaptive strategy was predicted to achieve this goal in over 50% of simulations within 5 years. In low-risk and moderate-risk communities, current WHO guidelines from 2012 were predicted to achieve morbidity control in most simulations (96% in low-risk and 41% for moderate-risk), although the proposed adaptive strategy reached this goal in a shorter period (mean reduction of 5 years). The model predicted that the addition of snail control to the proposed adaptive strategy would achieve morbidity control in all high-risk communities, and 54% of communities could reach the goal for elimination as a public health problem (<1% heavy infection) within 7 years.InterpretationThe modified adaptive decision making framework is predicted to be more effective than the current WHO guidelines in reaching 2025 public health goals, especially for high-prevalence regions. Modifications in current guidelines could reduce the time and resources needed for countries who are currently working on achieving public health goals against schistosomiasis.FundingUniversity of Georgia Research Foundation, The Bill & Melinda Gates Foundation, and the Medical Scientist Training Program at Stanford University School of Medicine.

Highlights

  • Schistosomiasis, a chronic disease caused by parasitic flukes of the genus Schistosoma, remains highly prevalent in many low-income and middle-income countries.[1]

  • We found that using the standard mass drug administration (MDA) treatment strategy for more than 2–3 years will lead to apparent stagnation in programme impact, resulting in no further progress towards control

  • The strength of infection rebound relative to drug-mediated reductions in prevalence determined the progress of the MDA regimen over time

Read more

Summary

Introduction

Schistosomiasis, a chronic disease caused by parasitic flukes of the genus Schistosoma, remains highly prevalent in many low-income and middle-income countries.[1]. Schistosomiasis is most often treated with praziquantel, which targets adult worms but does not protect the patient against reinfection.[4] Many schistosomiasis control programmes have reduced local disease prevalence in affected populations with the use of targeted mass drug administration (MDA) delivered as repeated school-based or community-wide treatments. Prevalence reduction has not been achieved in all treated communities,[5,6] and, in addition, at-risk areas often have a rebound of infection and disease prevalence after drug treatment efforts are stopped.[7,8] More effective disease control might be achieved through environmental modifications that separate humans from contaminated water sources,[9] or through snail population reductions with molluscicides, as these immediately reduce local snail populations and snail-to-human transmission.[10,11] www.thelancet.com/lancetgh Vol 7 October 2019

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.